Recent research has identified a potential link between low brain lithium levels and the progression of Alzheimer's disease. The study suggests tha...
Isaac Health, a health technology company specializing in brain health and dementia care, has announced a successful $10.5 million Series A funding...
AN2 Therapeutics, a clinical-stage biopharmaceutical company, has commenced its first-in-human clinical trial for the drug AN2-502998, aimed at tre...
Bayer and Kumquat Biosciences have entered into a global collaboration to develop a KRAS-G12D inhibitor for cancer treatment. Kumquat will lead the...
The U.S. cell and gene therapy clinical trials market is projected to grow significantly, reaching an estimated value of $14.68 billion by 2034, up...
Preventive neurology is gaining attention as a promising approach to managing Alzheimer's and Parkinson's diseases. Dr. Richard S. Isaacson and Dr....
AN2 Therapeutics has commenced its first-in-human clinical trial for AN2-502998, an oral drug candidate aimed at treating chronic Chagas disease. T...
Quince Therapeutics, a biotechnology company, has announced significant progress in its Phase 3 NEAT clinical trial, which evaluates the neurologic...
The Trump administration has implemented significant cuts to federal science funding, affecting research institutions across the United States. The...
Recent research suggests that travel may play a significant role in delaying the onset of dementia by stimulating mental activity. Studies indicate...